U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C32H55N4O.Br
Molecular Weight 591.709
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of THONZONIUM BROMIDE

SMILES

[Br-].CCCCCCCCCCCCCCCC[N+](C)(C)CCN(CC1=CC=C(OC)C=C1)C2=NC=CC=N2

InChI

InChIKey=WBWDWFZTSDZAIG-UHFFFAOYSA-M
InChI=1S/C32H55N4O.BrH/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-27-36(2,3)28-26-35(32-33-24-19-25-34-32)29-30-20-22-31(37-4)23-21-30;/h19-25H,5-18,26-29H2,1-4H3;1H/q+1;/p-1

HIDE SMILES / InChI
Thonzonium Bromide is a cationic surface-active compound. As an additive to pharmacologic formulations, thonzonium bromide causes dispersion and penetration of cellular debris and exudate, thereby promoting tissue contact of the administered medication. Thonzonium bromide is a component of FDA-approved Coly-Mycin S Otic, used for treating infections of the ear caused by certain bacteria. It has being shown that Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo, suggesting that Thonzonium bromide might be a useful alternative therapy in preventing or treating osteolytic diseases..

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
COLY-MYCIN S

Approved Use

Cortisporin®-TC Otic Suspension is indicated for the treatment of superficial bacterial infections of the external auditory canal, caused by organisms susceptible to the action of the antibiotics; and for the treatment of infections of mastoidectomy and fenestration cavities, caused by organisms susceptible to the antibiotics.

Launch Date

1962
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Thermal decomposition of thonzonium bromide.
1986 Oct
Inhibitors of V-ATPase proton transport reveal uncoupling functions of tether linking cytosolic and membrane domains of V0 subunit a (Vph1p).
2012 Mar 23
Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo.
2016 Mar 15
Patents

Sample Use Guides

Mice: 5 mg/kg body weight, subcutaneous injection
Route of Administration: Other
Mature osteoclasts (OCs) exposed to Thonzonium (100 or 200 nM) for 48 h demonstrated attenuated capacity to resorb bone (reduction of 30% and 80% respectively).
Name Type Language
THONZONIUM BROMIDE
MI   ORANGE BOOK   USAN   USP-RS   VANDF  
USAN  
Official Name English
THONZONIUM BROMIDE [USP-RS]
Common Name English
TONZONIUM BROMIDE [MART.]
Common Name English
THONZONIUM BROMIDE [MI]
Common Name English
NC-1264
Code English
COLY-MYCIN S COMPONENT THONZONIUM BROMIDE
Common Name English
THONZONIUM BROMIDE [USAN]
Common Name English
THONZONIUM BROMIDE [ORANGE BOOK]
Common Name English
THONZONIUM BROMIDE [VANDF]
Common Name English
NC 1264
Code English
HEXADECYL(2-((P-METHOXYBENZYL)-2-PYRIMIDINYLAMINO)ETHYL)DIMETHYLAMMONIUM BROMIDE
Common Name English
1-HEXADECANAMINIUM, N-(2-(((4-METHOXYPHENYL)METHYL)-2-PYRIMIDINYLAMINO)ETHYL)-N,N-DIMETHYL-, BROMIDE
Systematic Name English
Tonzonium bromide [WHO-DD]
Common Name English
tonzonium bromide [INN]
Common Name English
THONZIDE
Brand Name English
NSC-5648
Code English
THONZONIUM BROMIDE COMPONENT OF COLY-MYCIN S
Common Name English
TONZONIUM BROMIDE
INN   MART.   WHO-DD  
INN  
Official Name English
Classification Tree Code System Code
NCI_THESAURUS C83486
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
Code System Code Type Description
MERCK INDEX
m965
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
PRIMARY Merck Index
NCI_THESAURUS
C47754
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
PRIMARY
RS_ITEM_NUM
1667100
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
PRIMARY
EVMPD
SUB11189MIG
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
PRIMARY
RXCUI
221171
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
PRIMARY RxNorm
CAS
553-08-2
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
PRIMARY
NSC
5648
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
PRIMARY
PUBCHEM
11102
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
PRIMARY
WIKIPEDIA
THONZONIUM BROMIDE
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
PRIMARY
FDA UNII
JI2B19CR0R
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
PRIMARY
ECHA (EC/EINECS)
209-032-1
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
PRIMARY
DRUG BANK
DBSALT002554
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
PRIMARY
INN
1559
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
PRIMARY
ChEMBL
CHEMBL1201322
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
PRIMARY
DAILYMED
JI2B19CR0R
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
PRIMARY
EPA CompTox
DTXSID1045326
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
PRIMARY
SMS_ID
100000077771
Created by admin on Fri Dec 15 15:10:17 GMT 2023 , Edited by admin on Fri Dec 15 15:10:17 GMT 2023
PRIMARY